What are the Future Directions for DNMT Inhibitors?
Future research on DNMT inhibitors is focused on improving their specificity and reducing side effects. Combining DNMT inhibitors with other therapeutic agents, such as histone deacetylase inhibitors or immune checkpoint inhibitors, has shown promise in preclinical studies. Histological analysis will continue to play a vital role in these studies, providing valuable information on the cellular and tissue-level effects of these combination therapies.
